HomeInsightsStock Comparison

Nectar Lifescience Ltd vs Onesource Specialty Pharma Ltd Stock Comparison

Nectar Lifescience Ltd vs Onesource Specialty Pharma Ltd Stock Comparison

Last Updated on: Jun 14, 2025

Key Highlights

  • The Latest Trading Price of Nectar Lifescience Ltd is ₹ 23.37 as of 13 Jun 15:30.
  • The P/E Ratio of Nectar Lifescience Ltd changed from 7 on March 2020 to 136.9 on March 2024 . This represents a CAGR of 81.24% over 5 yearsThe P/E Ratio of OneSource Specialty Pharma Ltd changed from 0 on March 2020 to 0 on March 2024 . This represents a CAGR of 0.0% over 5 years.
  • The Market Cap of Nectar Lifescience Ltd changed from ₹ 221.79 crore on March 2020 to ₹ 675.25 crore on March 2024 . This represents a CAGR of 24.94% over 5 yearsThe Market Cap of OneSource Specialty Pharma Ltd changed from ₹ 0 crore on March 2020 to ₹ 0 crore on March 2024 . This represents a CAGR of 0.0% over 5 years.
  • The revenue of Nectar Lifescience Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 revenue of ₹ 455.56 crore. This represent the decline of -100% The revenue of OneSource Specialty Pharma Ltd for the Mar '25 is ₹ 428.84 crore as compare to the Dec '24 revenue of ₹ 399.28 crore. This represent the growth of 7.4%.
  • The ebitda of Nectar Lifescience Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 ebitda of ₹ 45.28 crore. This represent the decline of -100% The ebitda of OneSource Specialty Pharma Ltd for the Mar '25 is ₹ 184.72 crore as compare to the Dec '24 ebitda of ₹ 48.08 crore. This represent the growth of 284.19%.
  • The net profit of Nectar Lifescience Ltd changed from ₹ 1.82 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of -100.00% The net profit of OneSource Specialty Pharma Ltd changed from ₹ -107 crore to ₹ 98.5 crore over 8 quarters. This represents a CAGR of NaN% .
  • The Dividend Payout of Nectar Lifescience Ltd changed from 3.73 % on March 2020 to 0 % on March 2024 . This represents a CAGR of -100.00% over 5 yearsThe Dividend Payout of OneSource Specialty Pharma Ltd changed from 0 % on March 2020 to 0 % on March 2024 . This represents a CAGR of 0.0% over 5 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Nectar Lifescience Ltd

  • Nectar Lifescience Limited was incorporated on June 27, 1995 with the name 'Surya Medicare Limited'.
  • On March 26, 2004, Company changed their name from 'Surya Medicare Limited' to 'Nectar Lifescience Limited'.
  • NECLIFE is an integrated pharmaceutical organization, engaged in manufacturing and delivering high quality pharmaceutical products.
  • It is a global pharmaceutical company specializing in Cephalosporins.
  • Nectar excels in Cephalosporin APIs production with certified facilities meeting global standards.

About OneSource Specialty Pharma Ltd

  • Onesource Specialty Pharma Limited was incorporated as a Private Limited Company, with the name and style of Inbiopro Solutions Private Limited' dated June 12, 2007, was issued by the Registrar of Companies, Karnataka at Bangalore.
  • The Company name was then changed to Stelis Biopharma Private Limited', pursuant to a Scheme of Amalgamation and a Certificate of Incorporation dated December 24, 2014, was issued by the Registrar of Companies.
  • The status of the Company was then converted from a Private Limited Company to a Public Limited Company, and renamed as Stelis Biopharma Limited' dated July 31, 2021,.
  • Subsequently, the name was changed to its present Onesource Specialty Pharma Limited' on February 13, 2024, and a fresh Certificate of Incorporation dated February 13, 2024, was issued by the Registrar of Companies, Karnataka at Bangalore.

Nectar Lifescience Ltd News Hub

News

Nectar Lifescience schedules board meeting

Nectar Lifescience will hold a meeting of the Board of Directors of the Company on 30 May ...

Read more

28 May 2025 15:35

News

Nectar Lifesciences slumps after Mohali unit gets seven observations from EU authorities

In a regulatory filing made after market hours yesterday, the company stated that its API ...

Read more

11 Mar 2025 12:24

News

Nectar Lifescience announces board meeting date

Nectar Lifescience will hold a meeting of the Board of Directors of the Company on 31 Janu...

Read more

24 Jan 2025 16:30

News

Nectar Lifescience schedules board meeting

Nectar Lifescience will hold a meeting of the Board of Directors of the Company on 14 Nove...

Read more

04 Nov 2024 16:03

News

Nectar Lifescience to conduct AGM

Nectar Lifescience announced that the Annual General Meeting (AGM) of the company will be ...

Read more

20 Aug 2024 16:12

News

Nectar Lifescience to convene AGM

Nectar Lifescience announced that the Annual General Meeting (AGM) of the company will be ...

Read more

20 Aug 2024 10:47

OneSource Specialty Pharma Ltd News Hub

News

OneSource collaborates with Xbrane Biopharma AB

OneSource Specialty Pharma and Xbrane Biopharma AB, a Sweden-headquartered biotechnology c...

Read more

11 Jun 2025 09:07

News

Onesource Specialty edges higher after inking manufacturing pact with biotech firm Xbrane

Xbrane Biopharma AB is a biotechnology company. It develops biological drugs based on a pa...

Read more

11 Jun 2025 10:09

News

OneSource Specialty jumps as Bangalore facility passes USFDA check

The facility received a Voluntary Action Indicated (VAI) classification from the USFDA, fo...

Read more

10 Jun 2025 10:16

News

OneSource receives ratings action from India Ratings & Research

OneSource Specialty Pharma announced that India Ratings & Research has assigned the credit...

Read more

04 Jun 2025 12:48

News

OneSource Specialty Pharma to convene board meeting

OneSource Specialty Pharma will hold a meeting of the Board of Directors of the Company on...

Read more

30 Apr 2025 11:35

News

OneSource Specialty Pharma to convene board meeting

OneSource Specialty Pharma will hold a meeting of the Board of Directors of the Company on...

Read more

25 Jan 2025 10:23

SWOT Analysis Of Nectar Lifescience Ltd

Strength

3

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

SWOT Analysis Of OneSource Specialty Pharma Ltd

Strength

0

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Nectar Lifescience Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Nectar Lifescience Ltd and OneSource Specialty Pharma Ltd

Which company has a larger market capitalization, Nectar Lifescience Ltd or OneSource Specialty Pharma Ltd?

Market cap of Nectar Lifescience Ltd is 524 Cr while Market cap of OneSource Specialty Pharma Ltd is 23,165 Cr

What are the key factors driving the stock performance of Nectar Lifescience Ltd and OneSource Specialty Pharma Ltd?

The stock performance of Nectar Lifescience Ltd and OneSource Specialty Pharma Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Nectar Lifescience Ltd and OneSource Specialty Pharma Ltd?

As of June 14, 2025, the Nectar Lifescience Ltd stock price is INR ₹23.37. On the other hand, OneSource Specialty Pharma Ltd stock price is INR ₹2024.35.

How do dividend payouts of Nectar Lifescience Ltd and OneSource Specialty Pharma Ltd compare?

To compare the dividend payouts of Nectar Lifescience Ltd and OneSource Specialty Pharma Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions